Skip to main content

Table 3 Changes in API before and after surgery for patients with negative TM levels before surgery

From: Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment

(a)
 Negative TM presurgery Histology No. of patients (pre API ≥ 6) No. of API normalized cases (post API < 6) Normalization rate
  SCC All 40 34 85.0%
  CA125 All 60 54 90.0%
  CEA All 79 71 89.9%
  CA19–9 All 63 57 90.5%
  CEA, CA19–9, CA125 All 46 43 93.5%
(b)
 Negative TM presurgery Histology No. of patients (pre API ≥ 6) No. of API normalized cases (post API < 6) Normalization rate
  SCC Squamous cell Carcinoma 1 1 100%
  CA125 Adenocarcinoma 52 47 90.4%
  1. TM tumor marker